ZIOPHARM Oncology (ZIOP) To Offer 9.6M Shares
Tweet
Share
E-mailGet Alerts ZIOP Hot Sheet
Join SI Premium – FREE
ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) plans to sell 9,600,000 shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering.
Barclays Capital Inc. is acting as sole book-running manager in this offering.
Barclays Capital Inc. is acting as sole book-running manager in this offering.
Are you missing key trading opportunities? Upgrade to StreetInsider Premium and get a step ahead of the market - FREE TRIAL!
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
